PL1727786T3 - Kwasowe addycyjne sole kwasu 5-aminolewulinowego lub jego pochodnych - Google Patents

Kwasowe addycyjne sole kwasu 5-aminolewulinowego lub jego pochodnych

Info

Publication number
PL1727786T3
PL1727786T3 PL05732530T PL05732530T PL1727786T3 PL 1727786 T3 PL1727786 T3 PL 1727786T3 PL 05732530 T PL05732530 T PL 05732530T PL 05732530 T PL05732530 T PL 05732530T PL 1727786 T3 PL1727786 T3 PL 1727786T3
Authority
PL
Poland
Prior art keywords
acid
derivatives
ala
aminolevulinic
addition salts
Prior art date
Application number
PL05732530T
Other languages
English (en)
Polish (pl)
Inventor
Jon Erik Braenden
Aslak Godal
Nils Olav Nilsen
Jo Klaveness
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of PL1727786T3 publication Critical patent/PL1727786T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL05732530T 2004-03-26 2005-03-29 Kwasowe addycyjne sole kwasu 5-aminolewulinowego lub jego pochodnych PL1727786T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0406917.5A GB0406917D0 (en) 2004-03-26 2004-03-26 Compounds
EP05732530A EP1727786B1 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
PCT/GB2005/001236 WO2005092838A1 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives

Publications (1)

Publication Number Publication Date
PL1727786T3 true PL1727786T3 (pl) 2011-11-30

Family

ID=32188818

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05732530T PL1727786T3 (pl) 2004-03-26 2005-03-29 Kwasowe addycyjne sole kwasu 5-aminolewulinowego lub jego pochodnych

Country Status (15)

Country Link
US (2) US7888526B2 (https=)
EP (2) EP1727786B1 (https=)
JP (1) JP5164565B2 (https=)
CN (1) CN1938264B (https=)
AT (1) ATE514672T1 (https=)
AU (1) AU2005225616B2 (https=)
CA (1) CA2561050C (https=)
DK (1) DK1727786T3 (https=)
ES (2) ES2367789T3 (https=)
GB (1) GB0406917D0 (https=)
PL (1) PL1727786T3 (https=)
PT (1) PT1727786E (https=)
RU (1) RU2392266C2 (https=)
SI (1) SI1727786T1 (https=)
WO (1) WO2005092838A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005025614D1 (de) * 2004-03-30 2011-02-10 Cosmo Oil Co Ltd 5-aminolevulinsäure-phosphatsalz, verfahren zu dessen herstellung und dessen verwendung
JP4719483B2 (ja) * 2004-03-30 2011-07-06 コスモ石油株式会社 ５−アミノレブリン酸スルホン酸塩の製造方法
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
JP4934292B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 ５−アミノレブリン酸エステルリン酸類塩、その製造方法及びその用途
JP4934293B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 植物活力剤組成物
US20070225518A1 (en) * 2006-03-22 2007-09-27 Zvi Malik 5-Aminolevulinic acid salts and their use
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
JP4989153B2 (ja) 2006-08-15 2012-08-01 コスモ石油株式会社 ５−アミノレブリン酸リン酸塩の新規結晶及びその製造方法
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
WO2008106966A1 (en) * 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
CN103626639B (zh) * 2008-10-30 2016-12-07 阿彻丹尼尔斯米德兰德公司 用金属催化剂还原hmf醚
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
RU2526803C2 (ru) 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
CA2790827A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2394642A1 (en) 2010-06-10 2011-12-14 Universite De Geneve 5-ALA ester formulations and use thereof
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
WO2012086802A1 (ja) 2010-12-24 2012-06-28 アークレイ株式会社 癌細胞の検出方法
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2766049A1 (en) 2011-10-14 2014-08-20 Photocure ASA Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
CA2880422C (en) 2012-08-03 2021-02-09 Photocure Asa Derivatives of 5-aminolevulinic acid
WO2014026077A1 (en) 2012-08-10 2014-02-13 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
JP6595484B2 (ja) 2013-12-20 2019-10-23 ガルデルマ・リサーチ・アンド・デヴェロップメント 光損傷皮膚のパルス光力学的処置
EP3095464A1 (en) 2015-05-19 2016-11-23 Universite De Geneve 5-ala derivatives and use thereof
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
GB201522311D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
BR112018011965A2 (pt) 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN106187793A (zh) * 2016-01-26 2016-12-07 赵鸣 5‑氨基酮戊酸及其衍生物的盐化合物和应用
RU2611441C2 (ru) * 2016-04-28 2017-02-22 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) Способ получения гидрохлорида метилового эфира 5-аминолевулиновой кислоты
KR20190112096A (ko) 2017-02-06 2019-10-02 쓰리스킨 에이에스 자외선 차단제 조성물
CN108088838A (zh) * 2017-12-13 2018-05-29 西南大学 双[2,4,6-三氯苯基]草酸酯在测定链格孢霉毒素中的应用及方法
CN108440319B (zh) * 2018-04-26 2021-05-18 爱斯特（成都）生物制药股份有限公司 一种制备盐酸氨基乙酰丙酸的方法
EP3868372A1 (en) 2020-02-19 2021-08-25 JLP Health GmbH A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer
CN115671059B (zh) * 2022-11-17 2024-06-11 兆科药业（合肥）有限公司 一种盐酸氨酮戊酸冻干制剂及制备方法
CN116162038A (zh) * 2023-01-06 2023-05-26 河南省精细化工研究院有限公司 一种5-氨基乙酰丙酸盐酸盐的环保型生产工艺
CN120957714A (zh) 2023-03-07 2025-11-14 光治疗Asa公司 膀胱癌疗法
WO2026052815A1 (en) 2024-09-05 2026-03-12 Photocure Asa Use of hal in a method for predicting bladder cancer immunotherapy response

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JP2767318B2 (ja) * 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
EP0483714B1 (en) * 1990-10-29 1995-05-03 Japan Tobacco Inc. A method of preparing an acid additional salt of delta-aminolevulinic acid
US5284973A (en) * 1990-10-29 1994-02-08 Japan Tobacco Inc. Method of preparing an acid additional salt of delta-aminolevulinic acid
JP2613136B2 (ja) * 1991-05-14 1997-05-21 株式会社コスモ総合研究所 植物成長促進剤
JP2997979B2 (ja) 1993-01-20 2000-01-11 株式会社コスモ総合研究所 ５−アミノレブリン酸の製造方法
JP2887554B2 (ja) * 1993-08-19 1999-04-26 株式会社コスモ総合研究所 植物の蓚酸含量低減剤
US5489572A (en) 1993-08-19 1996-02-06 Cosmo Research Institue Methods for reducing nitrate nitrogen and oxalic acids contents nin plants
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
JPH07238063A (ja) 1994-02-25 1995-09-12 Cosmo Sogo Kenkyusho:Kk ５−アミノレブリン酸の回収精製法
JP2896963B2 (ja) 1994-11-28 1999-05-31 株式会社コスモ総合研究所 植物の耐塩性向上剤
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
ATE202076T1 (de) 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
US6992107B1 (en) * 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
DE69826487T2 (de) 1997-07-30 2005-12-01 Wyeth Trizyclische vasopressin-agonisten
US5907058A (en) * 1998-07-29 1999-05-25 Midwest Research Institute Synthesis of an acid addition salt of delta-aminolevulinic acid from 5-bromo levulinic acid esters
GB0018527D0 (en) 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
DE602005025614D1 (de) * 2004-03-30 2011-02-10 Cosmo Oil Co Ltd 5-aminolevulinsäure-phosphatsalz, verfahren zu dessen herstellung und dessen verwendung

Also Published As

Publication number Publication date
AU2005225616B2 (en) 2011-08-18
CA2561050A1 (en) 2005-10-06
DK1727786T3 (da) 2011-08-29
CN1938264A (zh) 2007-03-28
JP2007530523A (ja) 2007-11-01
SI1727786T1 (sl) 2011-09-30
US20080064752A1 (en) 2008-03-13
ES2639021T3 (es) 2017-10-25
AU2005225616A1 (en) 2005-10-06
CN1938264B (zh) 2012-05-23
US20110125012A1 (en) 2011-05-26
EP1727786B1 (en) 2011-06-29
RU2392266C2 (ru) 2010-06-20
GB0406917D0 (en) 2004-04-28
ATE514672T1 (de) 2011-07-15
US7888526B2 (en) 2011-02-15
CA2561050C (en) 2012-05-08
PT1727786E (pt) 2011-07-08
EP2308830B1 (en) 2017-06-14
ES2367789T3 (es) 2011-11-08
WO2005092838A1 (en) 2005-10-06
EP2308830A1 (en) 2011-04-13
EP1727786A1 (en) 2006-12-06
US8692014B2 (en) 2014-04-08
RU2006135487A (ru) 2008-05-10
JP5164565B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
SI1727786T1 (sl) Kisle dodatne soli 5-aminolevulinske kisline ali njenih derivatov
EP1780197A4 (en) 5-SUBSTITUTED 2-PHENYLAMINOBENZAMID AS MEK INHIBITOR
TNSN07148A1 (en) (biphenyl) carboxylic acids and derivatives thereof
GB0018528D0 (en) Compounds
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
EP2862581A3 (en) Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
WO2005099680A3 (en) Use of treprostinil to treat neuropathic diabetic foot ulcers
DK1814534T3 (da) Derivater af 5-aminolevulinsyre til behandling af acne
DE60327745D1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
MX2010008097A (es) Acido (-) 2-[1-(7-metil-2-(morfolin-4-il)-4-oxo-4h-pirido [1,2-a] pirimidin-9-il) etilamino]benzoico enantiomericamente puro, su uso en terapia medica, y una composicion farmaceutica que lo comprende - 026.
EP1596854A4 (en) TREATMENT OF DISEASES RELATED TO REDUCED STICK OXIDE BIOVERABILITY, INCLUDING INCREASED ARGINASE
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
WO2001085781A3 (en) Repair of nerve damage
PL377478A1 (pl) Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne
EA200802172A1 (ru) Замещенные бифенилкарбоновые кислоты и их производные
WO2007001940A3 (en) Imaging agents
WO2003006443A3 (de) 2-`4-(naphtalin-2yl)-thiazol-2-ylaminocarbonyl benzoesäure und 2-`4-(naphtalin-2yl)-pyrimidin-2-ylaminocarbonyl benzoesäure und andere verbindungen als telomerase-hemmer zur anwendung in der tumortherapie
DK1853248T3 (da) Anvendelse af salte, additionsforbindelser og kompleksforbindelser af quanidinoeddikesyre
WO2007119004A3 (fr) Methode de diagnostic in vitro ou ex vivo de desordres psychiatriques et/ou de dysbioses intestinales
DE60302676D1 (de) Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente
BR0316751A (pt) Análogos de gabapentina para fibromialgia e outros distúrbios relacionados
EA200401432A1 (ru) Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков
WO2003063858A3 (fr) Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires
EP2074998A3 (en) Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems